Scientists have developed a vitamin D pill to treat advanced prostate cancer.
Exposure to Vitamin D from sunlight is known to improve the prognosis of certain cancers.

US drug company Novacea has produced a pill which delivers a concentrated dose of the vitamin without running the risk of side-effects from an overdose.

Chemistry and Industry magazine reports that if clinical trials of the drug - Asentar (DN-101) - are successful it could be available by 2009 //

Data shows that rates of prostate cancer are higher in countries further away from the equator, where there is less exposure to sunlight.

Taking lots of multivitamins may increase the risk of deadly prostate cancer, say US researchers.
Their study showed taking multivitamins more than seven times a week was associated with an increased risk of advanced and fatal prostate cancer. //

Experts advised men to eat a healthy diet to reduce their risk of cancer.

The findings, based on data on nearly 300,000 men, indicated the risk of advanced prostate cancer is 32% higher in men who take multivitamins more than once a day than in those who do not take them at all.

Risk of fatal prostate cancer was almost double. //

In an accompanying editorial, European researchers said a high intake of fruit and vegetables has been shown to reduce the risk of cancer. //

There has been a lot of research into antioxidants such as vitamin C and E because it is believed they may protect cells against damage.

However, some analyses have suggested that beta-carotene, vitamin A and vitamin E supplements may shorten life rather than extend it. //

Prostate cancer is the second leading cause of cancer death in men. It kills one man every hour in the UK.

Vincent Pankoke ID'd Jewish Council member Arnold van den Bergh as most likely culprit.

UPDATE (Thu Jan 20): After the debacle on Tuesday, with the cancellation of 777 and 747-8 flights by multiple international airlines, it seems the FAA was embarrassed (or forced) into accelerating the issuance of AMOC approvals for additional altimeters, approving the 777 on Wednesday morning, and the number of altimeters approved and percentage of the US fleet covered has now grown very quickly:
Tuesday Jan 18: 2 altimeters and 45% of the US fleet
Wednesday Jan 19: 5 altimeters and 62% of the US fleet
Thursday Jan 20: 13 altimeters and 78% of the US fleet.

The result has been that most disruption has been avoided, although regional jets remain a concern, with some problems resulting from low visibility. However, the rapid pace of approvals, and the expectation from airlines that there won’t be “any material disruption going forward”, further discredits the FAA’s fearmongering over the weekend, not least because an AMOC has now been issued covering all 787 jets, which were supposedly the cause of greatest alarm. Suggestions that airlines would need to “swap out the altimeters” in a process lasting years and costing billions of dollars, also appear to be well wide of the mark. //

But the FAA’s statements appear to confirm that they are only issuing AMOCs approving altimeters to operate while the current 5G deployment restrictions remain in place: “The new safety buffer announced Tuesday around airports in the 5G deployment further expanded the number of airports available to planes with previously cleared altimeters to perform low-visibility landings.”

So it is perhaps no wonder Boeing is refusing to comment because they don’t want to get into a public shouting match with the FAA, despite the behind the scenes confrontation over the 777 at the beginning of this week outlined above. But you can be sure that many aviation interests are demanding that the restrictions continue permanently and the FAA is preparing for another showdown on July 5th, when the current six month period of restrictions is set to expire.